Five to ten million individuals are infected by Human T-cell Leukemia Virus type 1 (HTLV-1).
HTLV-1 is transmitted through prolonged breast-feeding, by sexual contacts and by …

Retroviruses are associated with a wide variety of diseases, including immunological,
neurological disorders, and different forms of cancer. Among retroviruses, Oncovirinae …

Human T cell leukemia/lymphoma virus Type 1 and 2 (HTLV-1 and HTLV-2), together with
their simian counterparts (STLV-1, STLV-2), belong to the Primate T lymphotropic viruses …

Human T-cell leukemia virus type 1 (HTLV-1) is a replication-competent human retrovirus
associated with two distinct types of diseases: a malignancy of mature CD4+ T cells called …

No effective treatment for TSP/HAM has been described so far. Interventions with
corticosteroids, plasmapheresis, interferon and, more recently, with antiretroviral drugs have …

HTLV-1 is a retrovirus which causes diverse diseases in 10% of its infected population,
significantly worsening their quality of life and mortality rate. Even though it is globally …

Human T cell leukemia virus type 1 (HTLV-1), the etiological agent of adult T-cell
leukemia/lymphoma (ATLL) and the demyelinating neuroinflammatory disease known as …

Studies of human T-cell leukemia virus type 1 (HTLV-1) have been hampered by the
difficulty of achieving high cell-free and cell-associated infectious titers. Current retroviral …

The African continent is considered the largest high endemic area for the oncogenic
retrovirus HTLV-1 with an estimated two to five million infected individuals. However, data on …

Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people
globally and can cause severe and potentially fatal disease, including adult T-cell …